Dmitry Balyasny’s Kura Oncology KURA Stock Holding History

Dmitry Balyasny’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-679,500	Closed	-$6.01M	–	3338
2025 Q3	$6.01M	Buy	+679,500	New	+$4.84M	0.01%	1287

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Dmitry Balyasny's KURA Position: Q4 2025 in Review

Dmitry Balyasny sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 86,798 shares — an estimated $768K sold.

Dmitry Balyasny first reported a position in KURA in Q2 2022 and held it in 10 quarters. The position peaked at $28.5M in Q4 2022. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

Dmitry Balyasny reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
Dmitry Balyasny sold 86,798 Kura Oncology shares in Q4 2025, an estimated $768K.
Dmitry Balyasny first reported a position in Kura Oncology in Q2 2022 and held it in 10 quarters.
Dmitry Balyasny's Kura Oncology position peaked at $28.5M in Q4 2022.
215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.